• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


China-based Raybow USA Expands Brevard, North Carolina, Campus

Raybow USA Inc, the North American unit of China-based Raybow Pharmaceuticals and global provider of outsourced pharmaceutical process development and manufacturing services, will expand its operations, tripling both its capacity and workforce, in Brevard, North Carolina.

The $15.8 million project is expected to create 74 jobs over the coming five years. The company, which currently employs 24 in Brevard, focuses on early-stage R&D and process research through Phase II clinical trials.

Peter Halkjaer-Knudsen, Executive Vice President of Raybow Pharmaceuticals said, "Raybow Pharmaceuticals is proud to announce that, a year since we acquired the Brevard site, we are ready to further increase our commitment in North Carolina. We are grateful for the warm welcome we have received and the continued support we experienced during the feasibility studies for this expansion. Transylvania County has proven to be the right choice for our North American headquarters and R&D operations and we very much look forward to the continued journey with the people of North Carolina."

New positions at Raybow USA will include research chemists, pilot-plant personnel and supervisors. Once the expansion is complete, the local region will benefit from a nearly $5.7 million payroll impact in the community, each and every year.

"North Carolina pioneered contract pharmaceutical discovery more than a generation ago, and today the industry connects many of our communities with global life sciences opportunities," said Commerce Secretary Machelle Sanders. "We welcome this major expansion by Raybow USA, whose local roots showcase the best traditions of entrepreneurship in our state."

The company was founded as PharmAgra Labs in 1999 by two North Carolina entrepreneurs. Today, the Brevard-based company is a publicly-held contract development and manufacturing organization that partners with leading pharmaceutical companies across Asia, Europe and North America.

Exclusive Research